ABSTRACT Antibody raised against the purified human erythrocyte glucose transporter specifically precipitated four proteins from normal and Rous sarcoma virus-transformed chicken embryo -cells: a major protein of Mr 41,000 and minor proteins of Mr 68,000, 73,000, and 82,000. The Mr41,000 and 82,0 proteins were found only in a membrane fraction, not in the soluble fraction, and displayed a heterogeneous mobility on NaDodSOd polyacrylamide gel electrophoresis, suggesting glycosylation. The Mr 41,000 and 82,000 proteins were increased in amount after malignant transformation in direct proportion to the increase in hexose transport rate, and the increase was dependent on the expression of the src gene product, as revealed with a temperature-conditional src mutant. We suggest that the Mr 41,000 and 82,000 proteins are the glucose transporter of chicken embryo fibroblasts, or a component of the glucose transporter. These experiments provide.direct evidence that malignant transformation increases the rate of glucose transport by increasing the number of transporters in the membrane.
Malignant transformation of chicken embryo cells by Rous sarcoma virus (RSV) causes a striking increase in the rate at which these cells transport glucose across the cell membrane (1) (2) (3) (4) . Despite much research, little is known about the molecular basis for this alteration. It is clear that the activity of the viral transforming protein pp6Osrc is essential for the increase in glucose transport because viral mutants coding for a temperaturesensitive pp6Osrc are temperature-sensitive in their ability to increase the transport rate (5, 6) . Inhibitor data suggest that the increased transport rate requires new protein synthesis but not new RNA synthesis (6, 7) . Induction of the increased, transport requires a functional nucleus (8) . The mechanism by which pp60src causes this increase in transport rate is completely unknown. In theory, it seems possible that pp6osrc could act (i) to increase the number ofnormal cellular transporters, (ii) to induce the synthesis of a new class of transporters, or (iii) to increase the activity of preexisting transporters. The fact that transformation results in an increase in the maximal velocity for transport but does not detectably change the half-saturation constant (2, 3) has been -used to argue for-the first hypothesis-namely, that transformation causes an increase in the number of normal carriers. However, this argument is a weak one because cases are known in which allosteric regulation causes an increase in the maximal velocity without affecting the half-saturation constant for substrate. (9) . Recently, Salter and Weber (10) demonstrated that a portion of the binding of cytochalasin B to chicken embryo cells could be stereospecifically inhibited by D-glucose, and this "glucose-specific" cytochalasin B binding was increased in transformed cells which displayed a high hexose transport rate. Because it had been shown that the purified glucose transporter from human erythrocytes bound cytochalasin B (11, 12) , this result provided strong, but still indirect, evidence for the suggestion that transformed cells contain increased numbers of glucose transporters in their membranes.
In addition to their cytochalasin binding properties the chicken embryo cell glucose transporter and the human erythrocyte glucose transporter share the following-features: both are facilitated diffusion systems (2, 13) and, to the extent that substrate specificity has been determined, both have similar specificities (2, 14) . These similarities suggested to us the possibility that the two proteins might have some antigenic similarities. Since Baldwin and Lienhard (14) recently characterized an antiserum prepared against the purified human erythrocyte transporter, it became possible to determine whether immunologically crossreactive proteins could be found in chicken embryo cell membranes and whether these proteins increased in amount during malignant transformation. While this work was in progress, Sogin and Hinkle (15) reported immunological crossreactivity between the human erythrocyte transporter and proteins of cultured mammalian cells. We have found proteins in chicken embryo cells that appear to be antigenically related to the human erythrocyte glucose transporter. Two of these proteins are probably glycosylated, are found in a crude membrane fraction, and increase in approximately direct proportion to the. glucose transport rate upon transformation.
MATERIALS AND METHODS
Virus Strains. The Schmidt-Ruppin strain of RSV subgroup A (SR-RSV) and its temperature-conditional mutant counterpart, tsNY68, were obtained originally from S. Kawai and H. Hanafusa (Rockefeller. University) (6) .
Sera. The preparation of preimmune serum (about 6 mg of IgG per ml) and antiserum against the human erythrocyte glucose transporter (about 13 mg ofIgG per ml) has been described (14) . Normal rabbit serum was prepared from an unrelated, unimmunized rabbit.
Other Materials.
[35S]Methionine, [32P]phosphate, and EN3HANCE were obtained from New England Nuclear. Protein A-Sepharose was obtained from Sigma. The human erythrocyte glucose transporter was purified in the presence of the detergent octaethylene glycol n-dodecyl ether and reconstituted with additional dioleoylphosphatidylcholine as described (16 Fig. 1 , which indicate a virusinduced increase in the production ofproteins antigenically related to the human erythrocyte glucose transporter, are the consequence ofvirus replication rather than transformation. To distinguish between these possibilities, we made use oftsNY68, a mutant coding for a temperature-sensitive pp6src. Cells infected with tsNY68 produce high titers ofinfectious virus at both 360C and at 420C but display the transformed phenotype only at 36°C (the permissive temperature) (6) . Fig. 2 demonstrates that the increased levels ofcrossreactive proteins depend on the activity ofpp6(Yrc. As in Fig. 1 (Fig. 3) (Fig. 3) . These surprising data may be a consequence of serendipitous crossreaction between certain chicken cell proteins and the natural antibodies of the rabbit used for 10 pl, plus bovine serum albumin; e, normal rabbit serum, 10 ,ul; f, preimmune serum, 10 ul. Although we believe that our antisera recognize the glucose transporter ofchicken embryo cells, we have been unsuccessful in attempts to immunoprecipitate D-glucose-inhibitable cytochalasin B binding activity from an octyl glucoside extract of transformed cells. We suspect that this is due to inefficient precipitation of the crossreactive proteins from the detergent extract. Nonetheless, these negative results point out both the difficulty and the importance of determining unambiguously the functional identity of the crossreactive proteins.
The transformation-related increase in the Mr 41,000 and 82,000 proteins is dependent on the activity of pp6Osrc because cells infected with a temperature-conditional mutant of RSV displayed the increase only at the permissive temperature. Because pp6OrC has been shown to be a protein kinase, it was of interest to determine whether the putative transporters were phosphorylated. We were unable to detect phosphorylation of any of the proteins specifically precipitated by our antiserum, under conditions in which we can readily detect phosphorylation of pp60rC itself (25) . Because the transporter and pp6(Y"' are present in cells in similar amounts (see above and ref. 26) we think that this negative result is significant. Thus, it seems unlikely that the glucose transporter is a primary target of pp60swrc.
Cell Biology: Salter et aL
Our data strongly suggest that the transformation-related increase in glucose transport rate is due to an increased number of normal cellular transporters. Because the Mr of the putative transporter is the same in normal and transformed cells and because our previous studies have not revealed changes in transport kinetics, specificity, or sensitivity to inhibitors (2, 10), neither a new transport system (27) nor allosteric effects are likely to play major roles in increasing the glucose transport rate in transformed cells.
